Skip to content
value.today

TAUNS Laboratories, Inc.

197A.T
No market cap data
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

TAUNS Laboratories, Inc. in brief

TAUNS Laboratories, Inc. is a listed company in the Healthcare sector, based in Japan. Its shares trade under the symbol 197A.T (Tokyo).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Market cap history

Not enough history yet.

Mutual funds holding TAUNS Laboratories, Inc.#

12 funds hold shares worth $1 M. Since their previous reports 0 added shares and 5 sold, selling $0 M net.
Mutual funds holding TAUNS Laboratories, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 WisdomTree Japan SmallCap Dividend FundWisdomTree Asset Management, Inc.84,100$0 M—0.07%−9.1%Jun 30, 2026
🇺🇸 WisdomTree International High Dividend FundWisdomTree Asset Management, Inc.45,000$0 M—0.02%−2.2%Jun 30, 2026
🇺🇸 Dimensional International Core Equity 2 ETFDimensional Fund Advisors LP19,000$0 M—<0.01%no changeJul 31, 2026
🇺🇸 WisdomTree International Equity FundWisdomTree Asset Management, Inc.18,900$0 M—<0.01%−1.6%Jun 30, 2026
🇺🇸 The Japanese Small Company SeriesDimensional Fund Advisors LP17,500$0 M—<0.01%−59%Jul 31, 2026
🇺🇸 International Core Equity 2 PortfolioDimensional Fund Advisors LP16,800$0 M—<0.01%no changeJul 31, 2026
🇺🇸 International Social Core Equity PortfolioDimensional Fund Advisors LP8,800$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional International Core Equity Market ETFDimensional Fund Advisors LP7,900$0 M—<0.01%no changeJul 31, 2026
🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP7,600$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional International Small Cap ETFDimensional Fund Advisors LP3,300$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP3,100$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional International Sustainability Core 1 ETFDimensional Fund Advisors LP400$0 M—<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 12 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

CompanyMarket capP/ENet marginRev. growth
TAUNS Laboratories, Inc.🇯🇵————
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
UnitedHealth Group Incorporated🇺🇸$367.7 B23.1×3.5%+11.8%
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Profile updated:
Nov 5, 2026

Figures from Japan Exchange Group, value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at TAUNS Laboratories, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show TAUNS Laboratories, Inc.'s ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about TAUNS Laboratories, Inc.? Suggest a correction